Multivariable analysis
| . | HR (95% CI) . | P . |
|---|---|---|
| Factors associated with overall mortality | ||
| Histology group | ||
| Indolent | 1.0 | |
| Aggressive or mantle cell | 19.3 (3.9-94.5) | < .001 |
| Baseline platelets < 25 000/μL | ||
| No | 1.0 | |
| Yes | 11.0 (2.4-50.9) | .002 |
| Donor type | ||
| Matched-related | 1.0 | |
| Matched-unrelated | 3.6 (1.1-12.2) | .04 |
| Factors associated with progression or mortality | ||
| Histology group | ||
| Indolent | 1.0 | |
| Aggressive or mantle cell | 14.6 (4.0-53.7) | < .001 |
| Maximal disease bulk > 5 cm | ||
| No | 1.0 | |
| Yes | 3.6 (1.3-9.9) | .01 |
| Baseline platelets < 25 000/μL | ||
| No | 1.0 | |
| Yes | 5.1 (1.4-18.1) | .01 |
| . | HR (95% CI) . | P . |
|---|---|---|
| Factors associated with overall mortality | ||
| Histology group | ||
| Indolent | 1.0 | |
| Aggressive or mantle cell | 19.3 (3.9-94.5) | < .001 |
| Baseline platelets < 25 000/μL | ||
| No | 1.0 | |
| Yes | 11.0 (2.4-50.9) | .002 |
| Donor type | ||
| Matched-related | 1.0 | |
| Matched-unrelated | 3.6 (1.1-12.2) | .04 |
| Factors associated with progression or mortality | ||
| Histology group | ||
| Indolent | 1.0 | |
| Aggressive or mantle cell | 14.6 (4.0-53.7) | < .001 |
| Maximal disease bulk > 5 cm | ||
| No | 1.0 | |
| Yes | 3.6 (1.3-9.9) | .01 |
| Baseline platelets < 25 000/μL | ||
| No | 1.0 | |
| Yes | 5.1 (1.4-18.1) | .01 |
HR indicates hazard ratio.